Gilead Sciences reported $565M in Trade Creditors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Agios Pharmaceuticals AGIO:US USD 10.42M 2.62M
ALKERMES ALKS:US USD 33.2M 6.85M
Alnylam Pharmaceuticals ALNY:US USD 40.57M 11.85M
Amgen AMGN:US USD 1.2B 52M
Biogen BIIB:US USD 383.2M 51.6M
Bluebird Bio BLUE:US USD 18.62M 6.24M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Coherus Biosciences CHRS:US USD 9.92M 7.57M
Eli Lilly And LLY:US USD 1.68B 23.9M
Intercept Pharmaceuticals ICPT:US USD 21.3M 9.64M
Moderna Inc MRNA:US USD 330M 149M
Novartis NOVN:VX USD 4.69B 276M
Ptc Therapeutics PTCT:US USD 20.86M 2.02M
Puma Biotechnology PBYI:US USD 14.93M 5.09M
Regeneron Pharmaceuticals REGN:US USD 535.6M 1.4M
Sangamo Biosciences SGMO:US USD 17.38M 4.3M
Sarepta Therapeutics SRPT:US USD 118.46M 62.25M
Teva Pharmaceutical Industries TEVA:US USD 1.64B 266M
Vertex Pharmaceuticals VRTX:US USD 126.9M 71.1M
YTE INCY:US USD 163.17M 31.6M